Bone Density Order

[comment memo="Patients who meet at least 1 of these criteria:\n\nWomen whose physician or qualified practitioner determines them estrogen-deficient and at clinical osteoporosis risk\nIndividuals with vertebral abnormalities\nIndividuals getting (or expecting to get) glucocorticoid therapy for more than 3 months\nIndividuals with primary hyperparathyroidism\nIndividuals monitored to assess FDA-approved osteoporosis drug therapy response"]
[text name="Age" memo="age" memo_size="small" size="5"] year old [select name="Race" value="White|African American"] [select name="Gender" memo="gender" memo_size="small" value="Male|Female"][conditional field="Gender|Age" condition="((Gender).is('Female'))&&((Age).isGreaterOrEqual('30')&&(Age).isLessOrEqual('64'))"] - [select name="wellvisitAPmenopause" value="premenopausal|perimenopausal|postmenopausal"][/conditional]

[select name="BoneDensity" value="77080 — Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)|77081 -  Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)|77085 — Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine), including vertebral fracture assessment"]

[checklist name="Diagnosis" value="Osteopenia M89.9|Osteoporosis M81.0|Screening for osteoporosis Z13.820|Asymptomatic menopausal state Z78.0|Long term use of systemic steroids Z79.52|Personal history of healed osteoporosis fracture Z87.310|Primary hyperparathyroidism E21.0|Hyperparathyroidism, unspecific E21.3|Asymptomatic postprocedural ovarian failure E89.40|Symptomatic postprocedural ovarian failure E89.41"]
Patients who meet at least 1 of these criteria: Women whose physician or qualified practitioner determines them estrogen-deficient and at clinical osteoporosis risk Individuals with vertebral abnormalities Individuals getting (or expecting to get) glucocorticoid therapy for more than 3 months Individuals with primary hyperparathyroidism Individuals monitored to assess FDA-approved osteoporosis drug therapy response
age year old gender



Result - Copy and paste this output:

Sandbox Metrics: Structured Data Index 0.83, 8 form elements, 2 boilerplate words, 1 text boxes, 1 check lists, 4 drop downs, 1 comments, 1 conditionals, 15 total clicks
Questions/General site feedback

Send Feedback for this SOAPnote

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More SOAPnotes by this Author: